413P Mismatch repair deficiency (MMRd) in esophagogastric adenocarcinoma (ADC) following chemotherapy for resectable disease: Correlation with survival and recurrence patterns from ST03 and OE05 trials

Ntellas, P., Keogh, G.A., Gordon, A. et al. (10 more authors) (2025) 413P Mismatch repair deficiency (MMRd) in esophagogastric adenocarcinoma (ADC) following chemotherapy for resectable disease: Correlation with survival and recurrence patterns from ST03 and OE05 trials. In: Annals of Oncology. ESMO Gastrointestinal Cancers Congress 2025, 02-05 Jul 2025, Barcelona, Spain. Elsevier, s162-s162. ISSN: 0923-7534. EISSN: 1569-8041.

Metadata

Item Type: Proceedings Paper
Authors/Creators:
  • Ntellas, P.
  • Keogh, G.A.
  • Gordon, A.
  • Lote, H.
  • Starling, N.
  • Chau, I.
  • Nankivell, M.G.
  • Langley, R.E.
  • Allum, W.H.
  • Salto-Tellez, M.
  • Lund, T.A.
  • Grabsch, H.I. ORCID logo https://orcid.org/0000-0001-9520-6228
  • Cunningham, D.
Dates:
  • Published: July 2025
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds)
Funding Information:
Funder
Grant number
Cancer Research UK Supplier No: 138573
NOT GIVEN
Cancer Research UK Supplier No: 138573
C26441/A9687
Date Deposited: 28 Jan 2026 09:06
Last Modified: 28 Jan 2026 09:06
Status: Published
Publisher: Elsevier
Identification Number: 10.1016/j.annonc.2025.05.429
Related URLs:
Open Archives Initiative ID (OAI ID):

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics

View Altmetric information about this item.


CORE (COnnecting REpositories)